The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
Second-generation antipsychotics (SGAs) are the mainstay of treatment for schizophrenia and other neuropsychiatric diseases but cause a high risk of disruption to lipid metabolism, which is an intractable therapeutic challenge worldwide. Although the exact mechanisms underlying this lipid disturbanc...
Saved in:
Main Authors: | Hui Chen (Author), Ting Cao (Author), Bikui Zhang (Author), Hualin Cai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
by: Zhenyu Zhu, et al.
Published: (2022) -
Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy
by: Tiantian Liang, et al.
Published: (2024) -
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
by: Qian Chen, et al.
Published: (2021) -
Integration of genomics, clinical characteristics and baseline biological profiles to predict the risk of liver injury induced by high-dose methotrexate
by: Chenquan Lin, et al.
Published: (2024) -
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
by: Shimeng Jiao, et al.
Published: (2022)